Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6307
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician ; volume:19 ; number:6 ; day:16 ; month:6 ; year:2017 ; pages:1-16 ; date:6.2017
Current rheumatology reports ; 19, Heft 6 (16.6.2017), 1-16, 6.2017
- Keyword
-
Hautkrankheit
Dermatologie
- Creator
-
Moots, Robert
- Contributor
-
Azevedo, Valderilio
Coindreau, Javier L.
Dörner, Thomas
Mahgoub, Ehab
Mysler, Eduardo
Scheinberg, Morton
Marshall, Lisa
SpringerLink (Online service)
- DOI
-
10.1007/s11926-017-0658-4
- URN
-
urn:nbn:de:1111-201709122653
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moots, Robert
- Azevedo, Valderilio
- Coindreau, Javier L.
- Dörner, Thomas
- Mahgoub, Ehab
- Mysler, Eduardo
- Scheinberg, Morton
- Marshall, Lisa
- SpringerLink (Online service)
Other Objects (12)
Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?
Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation
Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries
Abstracts / Research Symposium Rheumatology and Dermatology : Berlin, September 16 - 17, 2011
Biosimilars – Biosimilars: ja, aber
Biosimilars
Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review
The Price and Market Share Evolution of the Original Biologics and Their Biosimilars in Finland
What is the future of targeted therapy in rheumatology: biologics or small molecules?
Biosimilars : Handbuch
Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology
Dermatology
Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?
Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation
Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries
Abstracts / Research Symposium Rheumatology and Dermatology : Berlin, September 16 - 17, 2011
Biosimilars – Biosimilars: ja, aber
Biosimilars
Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review
The Price and Market Share Evolution of the Original Biologics and Their Biosimilars in Finland
What is the future of targeted therapy in rheumatology: biologics or small molecules?
Biosimilars : Handbuch
Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology
Dermatology
Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?
Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation
Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries
Abstracts / Research Symposium Rheumatology and Dermatology : Berlin, September 16 - 17, 2011
Biosimilars – Biosimilars: ja, aber
Biosimilars
Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review
The Price and Market Share Evolution of the Original Biologics and Their Biosimilars in Finland
What is the future of targeted therapy in rheumatology: biologics or small molecules?
Biosimilars : Handbuch
Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology